Macquarie Group’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-20
| Closed | -$37K | – | 2142 |
|
|
2018
Q4 | $37K | Sell |
20
-15
| -43% | -$27.8K | ﹤0.01% | 1660 |
|
|
2018
Q3 | $83K | Buy |
35
+21
| +150% | +$49.8K | ﹤0.01% | 1625 |
|
|
2018
Q2 | $49K | Sell |
14
-1
| -7% | -$3.5K | ﹤0.01% | 1952 |
|
|
2018
Q1 | $43K | Buy |
15
+12
| +400% | +$34.4K | ﹤0.01% | 2004 |
|
|
2017
Q4 | $6K | Sell |
3
-5,695
| -100% | -$11.4M | ﹤0.01% | 2340 |
|
|
2017
Q3 | $16.2M | Buy |
5,698
+689
| +14% | +$1.96M | 0.03% | 497 |
|
|
2017
Q2 | $11.8M | Buy |
5,009
+679
| +16% | +$1.61M | 0.02% | 567 |
|
|
2017
Q1 | $10.9M | Sell |
4,330
-1,097
| -20% | -$2.76M | 0.02% | 597 |
|
|
2016
Q4 | $12.2M | Buy |
5,427
+378
| +7% | +$853K | 0.02% | 562 |
|
|
2016
Q3 | $12.7M | Sell |
5,049
-4,588
| -48% | -$11.5M | 0.02% | 547 |
|
|
2016
Q2 | $29.5M | Buy |
9,637
+5,861
| +155% | +$17.9M | 0.03% | 466 |
|
|
2016
Q1 | $12M | Buy |
3,776
+304
| +9% | +$965K | 0.02% | 495 |
|
|
2015
Q4 | $17.8M | Sell |
3,472
-296
| -8% | -$1.52M | 0.04% | 383 |
|
|
2015
Q3 | $12M | Buy |
3,768
+766
| +26% | +$2.44M | 0.03% | 466 |
|
|
2015
Q2 | $12M | Buy |
3,002
+455
| +18% | +$1.82M | 0.02% | 475 |
|
|
2015
Q1 | $10.2M | Buy |
2,547
+728
| +40% | +$2.91M | 0.02% | 546 |
|
|
2014
Q4 | $8.92M | Buy |
1,819
+285
| +19% | +$1.4M | 0.02% | 552 |
|
|
2014
Q3 | $6.24M | Buy |
1,534
+338
| +28% | +$1.37M | 0.01% | 632 |
|
|
2014
Q2 | $4.84M | Buy |
1,196
+141
| +13% | +$570K | 0.01% | 714 |
|
|
2014
Q1 | $4.8M | Buy |
1,055
+276
| +35% | +$1.26M | 0.01% | 684 |
|
|
2013
Q4 | $2.73M | Buy |
779
+75
| +11% | +$263K | ﹤0.01% | 851 |
|
|
2013
Q3 | $2.9M | Sell |
704
-28
| -4% | -$115K | 0.01% | 778 |
|
|
2013
Q2 | $2.9M | Buy |
+732
| New | +$2.9M | 0.01% | 746 |
|